Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Sourav K. Mishra, M.D. / All India Institute of Medical Sciences.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Side by side
Philips North America — Warning letters0
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences — Warning letters1
Philips North America — Recalls355
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences — Recalls0
Philips North America — Approval records0
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences — Approval records0
Philips North America — Form 483s0
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences — Form 483s0
Timeline
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences
Most recent FDA action: April 29, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs Sourav K. Mishra, M.D. / All India Institute of Medical Sciences: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-sourav-k-mishra-m-d-all-india-institute-of-medical-sciences
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗